Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial

• Verfasst von: Dittrich, Sven [VerfasserIn]
• Verfasst von: Pattathu, Joseph George [VerfasserIn]
• Verfasst von: Ebinger, Friedrich [VerfasserIn]
• Titel: Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial
• Verf.angabe: Sven Dittrich, Erika Graf, Regina Trollmann, Ulrich Neudorf, Ulrike Schara, Antje Heilmann, Maja von der Hagen, Brigitte Stiller, Janbernd Kirschner, Robert Dalla Pozza, Wolfgang Müller-Felber, Katja Weiss, Katja von Au, Markus Khalil, Reinald Motz, Christoph Korenke, Martina Lange, Ekkehard Wilichowski, Joseph Pattathu, Friedrich Ebinger, Nicola Wiechmann, Rolf Schröder and on behalf of the German Competence Network for Congenital Heart Defects and the Treat-NMD Neuromuscular Network Investigators list of additional local Investigators and co-workers of the German Competence Network forCongenital Heart Defects and the Treat-NMD Neuromuscular Network
• Verlagsort: London
• Verlagsort: Heidelberg
• Verlag: BioMed Central
• Verlag: Universitätsbibliothek Heidelberg
• E-Jahr: 2019
• Jahr: 01 Aug. 2019
• Jahr: 01 Aug. 2019
• Umfang: 1 Online-Ressource (13 Seiten)
• Fussnoten: In: Orphanet Journal of Rare Diseases, 14 (2019), Nr. 105. pp. 1-13. ISSN 1750-1172
• URN: urn:nbn:de:bsz:16-heidok-264234
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1671461878
• K10plus-PPN:
  Universitätsbibliothek
• Lokale URL UB: Zum Volltext